921755-40-0 Usage
Uses
Used in Organic Synthesis:
Ethyl 2-(3,6-dihydro-2H-pyran-4-yl)-2-nitroacetate is used as a key intermediate in organic synthesis for the preparation of various heterocyclic compounds. Its unique dihydropyran ring structure allows for versatile chemical reactions, facilitating the creation of a broad range of complex organic molecules.
Used in Pharmaceutical Research:
In the pharmaceutical industry, ethyl 2-(3,6-dihydro-2H-pyran-4-yl)-2-nitroacetate serves as a valuable starting material for the development of new drugs. Its potential biological activities and chemical properties make it a promising candidate for the synthesis of pharmaceutical agents with novel therapeutic effects.
Used in Insecticide Development:
Ethyl 2-(3,6-dihydro-2H-pyran-4-yl)-2-nitroacetate has been studied for its insecticidal activity, making it a potential component in the development of new insecticides. Its ability to target and control pests can contribute to the creation of more effective and environmentally friendly pest management solutions.
Used in Drug Development:
ethyl 2-(3,6-dihydro-2H-pyran-4-yl)-2-nitroacetate's potential biological activities position it as a candidate for the development of new drugs with therapeutic applications. Its unique structure and properties can be leveraged to design and synthesize pharmaceutical agents that address specific medical needs.
Check Digit Verification of cas no
The CAS Registry Mumber 921755-40-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,2,1,7,5 and 5 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 921755-40:
(8*9)+(7*2)+(6*1)+(5*7)+(4*5)+(3*5)+(2*4)+(1*0)=170
170 % 10 = 0
So 921755-40-0 is a valid CAS Registry Number.
921755-40-0Relevant academic research and scientific papers
THE USE OF N-ARYL DIAZASPIRACYCLIC COMPOUNDS IN THE TREATMENT OF ADDICTION
-
Page/Page column 38, 73, (2010/10/20)
Compounds, compositions and methods for treating drug addiction, nicotine addiction, and/or obesity are disclosed. The compounds are N-aryl diazaspirocyclic compounds, bridged analogs of N-heteraryl diazaspirocyclic compounds, or prodrugs or metabolites of these compounds. The aryl group can be a five- or six-membered heterocyclic ring (heteroaryl). The compounds are effective at inhibiting dopamine production and/or secretion, and accordingly are effective at inhibiting the physiological "reward" process that is associated with ingestion of nicotine and/or illicit drugs. The compounds and compositions can be administered in effective amounts to inhibit dopamine release, wihout resulting in appreciable adverse side effects (e.g., side effects such as significant increases in blood pressure and heart rate, significant negative effects upon the gastro-intestinal tract, and significant effects upon skeletal muscle).
Synthesis of bicyclic tertiary α-amino acids
Strachan, Jon-Paul,Whitaker, Regina C.,Miller, Craig H.,Bhatti, Balwinder S.
, p. 9909 - 9911 (2007/10/03)
Novel bicyclic α-amino acids, exo and endo-1-azabicyclo-[2.2.1] heptane-2-carboxylic acid, 1-azabicyclo[2.2.1]heptane-7-carboxylic acid, and 1-azabicyclo[3.2.2]nonane-2-carboxylic acid have been readily synthesized for the generation of neuronal nicotinic receptor ligands. Alkylation of glycine-derived Schiff bases or nitroacetates with cyclic ether electrophiles, followed by acid-induced ring opening and cyclization in NH4OH, allowed for the preparation of substantial quantities of the three tertiary bicyclic α-amino acids.
